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Most pathogens gain access to the host through surfaces of the
body that are exposed to the surrounding environment and rife
with resident microorganisms, termed microbiota. Microbiota play
an integral role in modulating host health. One significant benefit
of the microbiota is that they provide protection against incoming
bacterial pathogens [1]. Commensals make their immediate
environment inhospitable to many pathogens by producing
biosurfactants, by competing for sites of attachment and nutrients,
and by excreting metabolites with antimicrobial effects [1].
Furthermore, the presence of commensals promotes maturation
of secondary lymphoid organs in the intestine, which are the first
line of defense in the intestinal mucosa [2]. Therefore, when a
pathogen infiltrates the host, it is not entering a sterile
environment, but one that has been shaped by a dynamic
commensal community. Although many interactions between
bacterial pathogens and the microbiota have been characterized
[1], little is known about the interplay between viral pathogens and
the natural flora of the host. Are viral pathogens blind to the
commensal microbes surrounding them? Judging from recent
publications, this appears not to be the case. There is strong
evidence that the microbiota can either protect the host from
virally induced disease or promote viral propagation/transmission,
through direct or indirect mechanisms.
Beneficial Influence of Microbiota on Antiviral
Immunity
Because the microbiota are present at the sites used by viruses to
gain entry to their host, they can potentially alter the outcome of
infection. For example, the commensal microbiota of the insect
vector Aedes aegypti indirectly mitigate Dengue virus transmission
[3]. Mosquitoes whose commensals are ablated by antibiotics have
higher viral titers than those that are left untreated. Moreover,
mosquitoes possessing their natural flora show elevated expression
of several immune-related genes, including those encoding
antimicrobial peptides regulated by Toll-like receptor (TLR)
pathways [3]. The authors hypothesize that the endogenous
bacterial flora stimulate the mosquitoes’ antiviral immune system
through basal-level activation of innate immune pathways.
Likewise, ablation of the natural flora of mice via antibiotic
treatment increases the animals susceptibility to influenza A virus
(Figure 1). Again, the mechanism of microbiota-mediated protec-
tion against the virus appears to be indirect—the microbiota are
responsible for activation of the inflammasome [4], which is
required for defense against influenza [5]. Inflammasome activa-
tion induces migration of dendritic cells from the lung to the
draining lymph node, to prime influenza-specific T-cell responses
[4]. Interestingly, a TLR agonist such as lipopolysaccharide (LPS)
added intranasally or intrarectally restores the immune response to
influenza in antibiotic-treated animals [4].
It should be stressed that both of the aforementioned studies
used antibiotics to alter the microbiota of the host. However,
antibiotic treatment can lead to changes in the host’s physiology
that are independent of microbiota disturbance. Additionally,
antibiotic treatment may not eliminate all microorganisms from
the host—many microbes are known to be resistant to antimicro-
bial therapies [6], and the majority of commensal species are
unculturable, making it difficult to prove the existence of an
antibiotic-induced sterile environment [7]. To subvert this
problem, one can use germ-free (GF) organisms. These organisms
are completely sterile, and exhibit normal developmental patterns
overall. However, both the gut associated lymphoid tissue and the
intestinal immune cells of these animals are underdeveloped.
Consequently, when studying the interaction between the host’s
microbiota and a given pathogen, it is imperative to use both
antibiotic-treated and GF animals to account for the limitations of
both experimental systems.
Indirect Promotion of Viral Infections by
Commensal Microbiota
Although microbiota can help the host fight viral infections, as
in the case of influenza, it may also enhance viral infection, either
indirectly or directly. One example of the indirect beneficial effects
of microbiota on virus replication is the promotion of viral
infection by stimulating the proliferation or activation of target
cells (Figure 1). This is particularly true of retroviruses that target
proliferating cells. For example, GF mice infected with murine
leukemia virus (MuLV) are relatively resistant to virally induced
leukemia compared to conventionally housed or specific pathogen
free (SPF) mice [8,9]. Immunization of MuLV-infected GF mice
with sheep red blood cells results in a significant increase in
leukemia development comparable to that of infected SPF mice
[9]. The authors hypothesize that the decrease of MuLV
pathogenicity in GF mice could be due to microbiota-stimulated
division of lymphoid cells, which would cause an increase in virus
replication and, thus, a higher frequency of leukemia. It should be
noted that other studies demonstrate that GF mice are more
susceptible than SPF mice to MuLV-induced leukemia [10], which
conflicts with the aforementioned findings. One potential expla-
nation for this discrepancy is that the studies showing increased
susceptibility of GF mice to MuLV were conducted before it was
revealed that some MuLV isolates contain a contaminating lactate
dehydrogenase-elevating virus (LDV). LDV induces systemic
lymphocyte activation [11] and could have skewed the results of
the investigations.
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To date, two studies, including our own, indicate that viruses
from three distinct families rely on commensal organisms for
efficient replication/transmission [12,13]. In the first study, Kuss
et al. found that antibiotic-treated, poliovirus-susceptible mice
show lower mortality following oral poliovirus infection compared
to untreated mice (Figure 1). Importantly, replication of the virus
in the mouse intestines is dependent on the microbiota, as GF or
antibiotic-treated mice secrete poorly infectious virus. Gram-
negative or Gram-positive bacteria incubated with poliovirus
greatly promote virus infectivity in tissue culture cells. This
enhancement did not require live bacteria, as bacterial surface
polysaccharides, including LPS and peptidoglycan (PG), have the
same effect on virus infectivity [12]. Importantly, these findings
were not unique to poliovirus; the pathogenesis of reovirus, an
unrelated enteric virus, is also more severe in the presence of
intestinal microbes [12].
We discovered that Mouse Mammary Tumor Virus (MMTV), a
retrovirus transmitted through the milk, utilizes the innate immune
Toll-like receptor TLR4 to induce tolerance to itself, and thus to
evade the antiviral response (Figure 1) [13]. Triggering of TLR4
by the virus results in interleukin 6 (IL-6)-mediated production of
the immunosuppressive cytokine IL-10, which is required for
blockage of the antiviral response [13]. MMTV does not signal
directly through TLR4 but uses LPS, a well-characterized TLR4
ligand, to trigger the receptor, as LPS-free MMTV stocks fail to
induce IL-10 production. Furthermore, GF mice infected with
MMTV by intraperitoneal injection are unable to transmit
infectious virus to their offspring. Therefore, MMTV exploits
tolerogenic properties of commensal bacteria to induce unrespon-
siveness to itself. Together, the two studies reveal that orally
transmitted viruses from three diverse families take advantage of
the gut microbiota for successful propagation. Exploitation of the
microbiota of the host can now be added to the list of innovative
evasion strategies used by viruses.
Do Lentiviruses Utilize Microbiota for Their
Benefit?
Like the viruses described in the preceding section, HIV-1 is
also transmitted across mucosal surfaces, which are rich in
microbiota. This prompts the question—do the microbiota
contribute to infection with HIV-1? People chronically infected
with HIV exhibit raised plasma levels of LPS [14]. Moreover, the
peptide derived from the V3 loop of gp120 specifically interacts
with the lipid A moiety of LPS, as does the full gp120 protein [15].
In addition, glycerol monolaurate, a widely used antimicrobial
Figure 1. An overview of how the commensal microbiota influence viral pathogenesis. Protection: The microbiota of the host activates
the inflammasome by priming signal 1 for IL-1b and IL-18 secretion. The secretion of these cytokines induces migration of dendritic cells from the
lung to the draining lymph node, where they prime T cells. The downstream effect of T-cell priming is protection of the host against influenza virus-
induced pathology. Indirect promotion: In the case of MuLV, the microbiota of the host stimulate proliferation of lymphoid cells that are targeted by
the virus. Direct promotion: Microbial ligands, such as LPS, are utilized by viruses to enhance their attachment to target cells (polio virus and reovirus)
or to counteract the antivirus immune response by activating the TLR4 pathway, which leads to IL-10 production (MMTV).
doi:10.1371/journal.ppat.1002681.g001
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simian immunodeficiency virus (SIV) [16]. Therefore, it is possible
that HIV and SIV may also take advantage of commensal bacteria
to assure successful propagation and spread.
Concluding Remarks
With the advent of the Human Microbiome Project, we are now
aware of the number and diversity of microbes that make the
human body their primary place of residence. Consequently, the
microbiota can no longer be ignored when studying host–
pathogen interactions. The influences of microbiota on virus
infections could be either protective or detrimental for the host.
Whereas the microbiota positively regulate adaptive immune
responses against influenza, they suppress antivirus adaptive
responses against MMTV and facilitate replication of poliovirus
and reovirus by enhancing virus attachment to target cells. Thus,
microbiota play a dual role in virus–host interactions. An open
question that currently drives research related to microbiota is how
the microbiota can be manipulated so that the host is protected
from deleterious infections. In the case of pathogens that take
advantage of the microbiota, one can hope to find a way to ablate
these interactions, thus preventing pathogen spread/propagation.
This could be done either by manipulating the composition of the
microbiota (ablation of a specific microbe exploited by a virus) or
by blocking interactions between the viral pathogen and specific
bacterial compounds that benefit the pathogen. Future discoveries
in the area of microbiota–pathogen interactions will undoubtedly
unveil new opportunities for therapeutic interventions in infectious
disease.
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